Allied Biotech Corporation (TPEX:1780)
Taiwan
· Delayed Price · Currency is TWD 26.00
-0.40 (-1.52%)
Mar 9, 2026, 1:17 PM CST
Allied Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,512 | 1,666 | 1,580 | 1,340 | 1,454 | 1,603 | Upgrade
|
| Market Cap Growth | 47.79% | 5.41% | 17.93% | -7.84% | -9.31% | -3.78% | Upgrade
|
| Enterprise Value | 2,465 | 1,603 | 1,584 | 1,422 | 1,463 | 1,516 | Upgrade
|
| Last Close Price | 26.10 | 16.44 | 14.91 | 11.85 | 12.40 | 13.05 | Upgrade
|
| PE Ratio | 26.62 | 16.51 | 16.22 | 9.13 | 111.49 | 20.18 | Upgrade
|
| PS Ratio | 3.06 | 2.07 | 2.19 | 1.87 | 2.15 | 2.59 | Upgrade
|
| PB Ratio | 2.12 | 1.39 | 1.35 | 1.13 | 1.35 | 1.40 | Upgrade
|
| P/TBV Ratio | 2.12 | 1.39 | 1.35 | 1.13 | 1.35 | 1.40 | Upgrade
|
| P/FCF Ratio | 18.25 | 8.46 | 17.62 | 12.23 | 64.80 | 603.66 | Upgrade
|
| P/OCF Ratio | 14.89 | 7.44 | 11.48 | 8.16 | 20.08 | 26.96 | Upgrade
|
| EV/Sales Ratio | 3.00 | 1.99 | 2.20 | 1.98 | 2.16 | 2.45 | Upgrade
|
| EV/EBITDA Ratio | 13.31 | 11.11 | 10.40 | 8.61 | 8.58 | 9.59 | Upgrade
|
| EV/EBIT Ratio | 19.86 | 18.19 | 17.86 | 14.25 | 13.10 | 14.78 | Upgrade
|
| EV/FCF Ratio | 17.91 | 8.14 | 17.66 | 12.98 | 65.19 | 570.73 | Upgrade
|
| Debt / Equity Ratio | 0.84 | 0.80 | 0.68 | 0.71 | 1.15 | 0.87 | Upgrade
|
| Debt / EBITDA Ratio | 5.38 | 6.36 | 5.03 | 4.88 | 7.03 | 6.09 | Upgrade
|
| Debt / FCF Ratio | 7.24 | 4.84 | 8.87 | 7.64 | 55.38 | 376.46 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.03 | 0.06 | 0.04 | 0.09 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.26 | -0.23 | 0.46 | 0.27 | 0.58 | 0.26 | Upgrade
|
| Net Debt / FCF Ratio | -0.34 | -0.17 | 0.79 | 0.40 | 4.39 | 15.26 | Upgrade
|
| Asset Turnover | - | 0.37 | 0.34 | 0.31 | 0.29 | 0.29 | Upgrade
|
| Inventory Turnover | - | 0.97 | 0.79 | 0.81 | 0.84 | 0.82 | Upgrade
|
| Quick Ratio | 1.12 | 1.12 | 1.01 | 1.02 | 0.93 | 1.11 | Upgrade
|
| Current Ratio | 1.61 | 1.67 | 1.76 | 1.72 | 1.33 | 1.63 | Upgrade
|
| Return on Equity (ROE) | - | 8.54% | 8.28% | 12.96% | 1.17% | 6.91% | Upgrade
|
| Return on Assets (ROA) | - | 2.54% | 2.60% | 2.70% | 2.97% | 3.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.24% | 5.70% | 5.72% | 6.57% | 7.00% | 7.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.10% | 7.00% | 7.10% | 7.70% | 10.20% | 8.00% | Upgrade
|
| Earnings Yield | 3.77% | 6.06% | 6.16% | 10.95% | 0.90% | 4.96% | Upgrade
|
| FCF Yield | 5.48% | 11.82% | 5.68% | 8.18% | 1.54% | 0.17% | Upgrade
|
| Dividend Yield | 3.79% | 6.08% | 5.70% | 10.13% | 4.03% | 6.13% | Upgrade
|
| Payout Ratio | 101.51% | 80.66% | 117.50% | 32.49% | 583.66% | 119.40% | Upgrade
|
| Buyback Yield / Dilution | -0.31% | -0.37% | -0.20% | -0.43% | -0.05% | -0.22% | Upgrade
|
| Total Shareholder Return | 3.48% | 5.71% | 5.50% | 9.69% | 3.98% | 5.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.